In recent trading, shares of Masimo Corp. (Symbol: MASI) have crossed above the average analyst 12-month target price of $197.75, changing hands for $200.63/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on val
In recent trading, shares of Amedisys, Inc. (Symbol: AMED) have crossed above the average analyst 12-month target price of $199.17, changing hands for $205.91/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on v
To become a "Dividend Aristocrat," a dividend paying company must accomplish an incredible feat: consistently increase shareholder dividends every year for at least 20 consecutive years. Companies with this kind of track record tend to attract a lot of investor attention — an
In recent trading, shares of DexCom Inc (Symbol: DXCM) have crossed above the average analyst 12-month target price of $286.75, changing hands for $291.69/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valua
The Lovesac Company (LOVE) came out with quarterly earnings of $0.37 per share, beating the Zacks Consensus Estimate of $0.31 per share. This compares to earnings of $0.63 per share a year ago. These figures are adjusted for non-recurring items.
Sonoco (SON) came out with quarterly earnings of $0.94 per share, beating the Zacks Consensus Estimate of $0.84 per share. This compares to earnings of $0.85 per share a year ago. These figures are adjusted for non-recurring items.
Chevron CVX has suspended all construction work related to basic production and will instead only conduct critical work on its $45-billion Tengiz field expansion project in Kazakhstan due to the coronavirus pandemic. The critical work includes building of pipelines in Kazakhstan
Chesapeake Energy Corporation CHK recently performed a reverse stock split to boost share price but failed to arrest the decline in the stock, as it tumbled 37.6% yesterday.
G-III Apparel Group, Ltd. (GIII) is just trying to survive the coronavirus crisis. This Zacks Rank #5 (Strong Sell) has already fallen 71% year-to-date.G-III Apparel is a specialty retailer which makes apparel and accessories under their own, licensed and private label brands.G-
Investors weighed the latest batch of corporate earnings and economic data showing yet again how the coronavirus and associated shutdowns are taking a bite out of U.S. economic activity.
European stocks and U.S. futures advanced on Thursday, recovering some lost ground as world leaders take tentative steps to reopen economies hammered by the coronavirus.
Investors trimmed short positions on Asian currencies, a Reuters poll showed, as China tries to jump-start its economy that has been ravaged by the coronavirus pandemic, and as a slew of measures by the U.S. Federal Reserve eased worries about dollar liquidity.
Most Japanese corporations were disappointed by the government's $1 trillion stimulus plan to mitigate the economic fallout from the coronavirus outbreak, saying it is insufficient, and many complained it was too little, too late, a Reuters poll showed.
Australia is likely already deep into its first recession in three decades as entire sectors of the economy are shut to fight the new coronavirus, throwing tens of thousands out of work and threatening the survival of many businesses.
Japanese business confidence plunged to fresh decade lows in April as firms reported widespread damage from the coronavirus pandemic which is threatening to throw the world economy into recession, the Reuters Tankan survey showed on Thursday.
Microsoft (MSFT) closed at $171.88 in the latest trading session, marking a -1.05% move from the prior day. This change was narrower than the S&P 500's daily loss of 2.2%. Meanwhile, the Dow lost 1.86%, and the Nasdaq, a tech-heavy index, lost 1.44%.
In the latest trading session, Pfizer (PFE) closed at $35.98, marking a -1.26% move from the previous day. This change was narrower than the S&P 500's 2.2% loss on the day. Meanwhile, the Dow lost 1.86%, and the Nasdaq, a tech-heavy index, lost 1.44%.
In the latest trading session, CVS Health (CVS) closed at $60.56, marking a -1.62% move from the previous day. This move was narrower than the S&P 500's daily loss of 2.2%. Meanwhile, the Dow lost 1.86%, and the Nasdaq, a tech-heavy index, lost 1.44%.
Zacks
Checked
29 minutes 23 seconds ago
This feed is responsible for generating the rss feed related to the topic Stocks